aanooch, companies don't devulge cash on hand until reporting time peiod, unless they have completed a stock offering. As far as updates on drugs, I concur there should be more openness with shareholders and promisses of more updates hasn't materialized and they don't update their website often either.
On the other had there is so much potential here near term and long term complaining about management is #$%$ in the wind. Hiorst stated that the company would be cash and net income positive in 2013. How many biotech's can say that. Very, very few and with new products in the next two years, the company will be more and more profitable. I wonder what they are going to do in a couple of years with all the cash they will accummulate once the miraine drug, PAR drug, ED drug are generating cash flow along with Forfivo. I know there are a lot of traders in the market and instant gratification is rampant, but for LT investors this stock will generate 400% to 800% by 2016, if not 2015 with those drugs I mentioned coming to market as projected.